tirzepatide in a vial + Vitamin B12 10 mg/ml (2ml vial) Zepbound 15 mg/0.5 mL injection

this improves transparency, but review authenticity may vary

Intended Use: This product is crafted for research and educational exploration, empowering you with reliable insightswhile we encourage consulting your healthcare provider for personalized guidance

Novo Nordisk Foundation Center for Basic Metabolic Research is an independent Research Center, based at the University of Copenhagen, Denmark and partially funded by an unconditional donation from the Novo Nordisk Foundation ( (Grant number NNF18CC0034900)

Some research community protocols combine 5-Amino-1MQ with AOD-9604 (fat oxidation) or with a GLP-1 drug like semaglutide (appetite suppression), since the mechanisms do not overlap

Developed by Danish pharmaceutical giant Novo Nordisk, semaglutide has consistently generated billions in annual sales, with Wegovy alone posting multi-billion-dollar revenue figures before patent expirations loomed

Reuters: Coverage on Tirzepatides Effects and Approvals Important Medical Information and Disclaimers Important Current Status Update : On March 19, 2025, the FDA ended enforcement discretion for compounded tirzepatide